2.50
price down icon1.19%   -0.03
after-market Handel nachbörslich: 2.55 0.05 +2.00%
loading

Finanzdaten der Cardiff Oncology Inc-Aktie (CRDF)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
31.41%
0.205
0.156 0.141 0.108 0.083
Operating Expenses
6.20%
11.14
10.49 10.96 12.32 12.13
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
6.20%
11.14
10.49 10.96 12.32 12.13
Operating Income/Loss
5.82%
-10.93
-10.33 -10.82 -12.21 -12.05
Nonoperating Income/Loss
7.34%
0.922
0.995 1.089 1.058 0.829
Income/Loss From Continuing Operations Before Tax
31.41%
0.205
0.156 0.141 -11.15 -11.22
Income/Loss From Continuing Operations After Tax
7.22%
-10.01
-9.337 -9.731 -11.15 -11.22
Net Income/Loss
7.22%
-10.01
-9.337 -9.731 -11.15 -11.22
Preferred Stock Dividends And Other Adjustments
0.00%
0.006
0.006 0.006 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
44.68
- 44.68 44.68 44.68
Diluted Average Shares
44.68
- 44.68 44.68 44.68
Basic Earnings Per Share
4.76%
-0.22
-0.21 -0.22 -0.25 -0.25
Diluted Earnings Per Share
4.76%
-0.22
-0.21 -0.22 -0.25 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
0.00%
0.006
0.006 0.006 - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Kapitalisierung:     |  Volumen (24h):